These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2943805)

  • 1. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
    Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
    J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
    Christadoss P; Lennon VA; Krco CJ; David CS
    J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
    J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for myasthenia gravis: a murine model.
    Christadoss P; Dauphinee MJ
    J Immunol; 1986 Apr; 136(7):2437-40. PubMed ID: 2419435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
    J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules.
    Christadoss P; Lennon VA; Krco CJ; Lambert EH; David CS
    Ann N Y Acad Sci; 1981; 377():258-77. PubMed ID: 6803646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mouse model of autoimmune ocular myasthenia gravis.
    Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.
    Killen JA; Lindstrom JM
    J Immunol; 1984 Nov; 133(5):2549-53. PubMed ID: 6332854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.